Abstract: The purpose of the present invention is to provide a modified activin A. The present invention provides activin A comprising a modified proregion.
Type:
Application
Filed:
May 14, 2021
Publication date:
September 2, 2021
Applicants:
Mitsubishi Chemical Corporation, UniBio Corporation